The approach used for isolation of the Mycosynthetix fungal collection has enabled us to assemble great diversity with Ascomycete, Basidiomycete, Deuteromycete and Zygomycete representation, including many slow-growing less common organisms, many of which remain unidentified and undoubtably include those not described in the literature.
A wide variety of biologically active compounds are produced by our fungi; we have documented activity against bacterial, viral, fungal and parasitic infectious disease targets, compounds with potential for treating cancer, diabetes and other metabolic disorders, transcription regulators with potential for a wide variety of targets including blood disorders such as anemia, CNS associated targets, and a variety of agricultural targets and pesticides. More details are provided elsewhere on this site, as well as in our publications, some of which are listed.
Fungi are extremely talented synthetic chemists and produce a wide variety of complex and simple metabolites derived from organic and fatty acids (for example polyketides), isoprene and terpenes, D and L amino acids, sugars and bases. Click here to see some of the metabolites which have been identified from our fungi.
Fungi are a documented source of enzymes for commercial use: Mycosynthetix is seeking a partner to exploit our collection for new and better enzymes with industrial application.
Our fungal collection contains in excess of 55,000 isolates which together contain many millions of genes – please contact us to discuss your interest in this area.
Fungi produce one of the best known biofuels – ethanol. We believe that there are many potential biofuel applications for fungi — such as converting cellulose to simple sugars — and Mycosynthetix is exploring this.